Trademark: 98347437
Word
CTX211
Status
Pending
Status Code
641
Status Date
Thursday, May 9, 2024
Serial Number
98347437
Mark Type
4
Filing Date
Monday, January 8, 2024

Trademark Owner History

Classifications
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
CTX TWO HUNDRED ELEVEN
CTX TWO ONE ONE

Trademark Events
Jan 8, 2024
New Application Entered
Apr 26, 2024
New Application Office Supplied Data Entered
May 1, 2024
Assigned To Examiner
May 9, 2024
Notification Of Non-Final Action E-Mailed
May 9, 2024
Non-Final Action E-Mailed
May 9, 2024
Non-Final Action Written

Trademark Alertz updated from USPTO on 2030-01-24